Affiliations: [a] Centre for Age-Related Medicine, Stavanger University Hospital, Stavanger, Norway
| [b] Department of Clinical Sciences, University of Bergen, Bergen, Norway
| [c] Department of Cardiology, Stavanger University Hospital, Stavanger, Norway
| [d] Institute of Psychiatry, Psychology & Neuroscience, King’s College, London, UK
| [e] Department of Research, Section of Biostatistics, Stavanger University Hospital, Stavanger, Norway
Correspondence:
[*]
Correspondence to: Anne Katrine Bergland, MD, Department of Internal Medicine, Stavanger University Hospital, Postboks 8100, 4068 Stavanger, Norway. Tel.: +47 91595103; Fax: +47 51515161; E-mail: anne.katrine.bergland@sus.no and Hogne Soennesyn, Department of Internal Medicine, Stavanger University Hospital, Postboks 8100, 4068 Stavanger, Norway. Tel.: +47 0047 48232854; Fax: +47 0047 51515161; E-mail: hogne.sonnesyn@sus.no.
Abstract: Background: Vascular risk factors (VRF) are associated with an increased risk of neurodegenerative disease. Objective: To examine the association between VRF and cognitive decline in patients with Alzheimer’s disease (AD) and Lewy body dementia (LBD). Methods: We included consecutive referrals with mild AD or LBD to dementia clinics in western Norway from 2005 to 2013. The Mini-Mental Status Exam (MMSE) and Clinical Dementia Rating Scale Sum of Boxes (CDR-SB) were administered at baseline and then annually for up to five years. The VRF include diabetes mellitus, hypertension, hypercholesterolemia, overweight and smoking. Generalized Estimating Equations (GEE) were used to examine the potential association between VRF scores and the change in MMSE and CDR-SB scores, adjusting for age, sex, and the apolipoprotein ɛ4 allele (APOE4). Results: A total of 200 patients were included (113 AD, 87 LBD) (mean age 76 years, mean baseline MMSE 24.0, mean follow-up time 3.5 years). Smoking was the only VRF significantly associated with a more rapid cognitive decline, however only in the AD group. Being overweight at baseline was associated with a slower cognitive decline. Moreover, hypertension at baseline predicted a slower decline in MMSE scores. In the LBD group diabetes mellitus was found to be associated with a slower increase in CDR-SB scores. Conclusion: With the exception of smoking, VRF at time of dementia diagnosis were not associated with a more rapid cognitive decline.
